Serum 5-LOX: a progressive protein marker for breast cancer and new approach for therapeutic target
- 18 July 2016
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 37 (9) , 912-917
Abstract
Lipoxygenase (LOX) pathway has emerged to have a role in carcinogenesis. There is an evidence that both 12-LOX and 5-LOX have pro-carcinogenic role. We have previously reported the elevated level of serum 12-LOX in breast cancer patients. This study evaluated the serum level of 5-LOX in breast cancer patients and its in-vitro inhibition assessment with peptide inhibitor YWCS. The level of 5-LOX was determined by surface Plasmon resonance (SPR). The peptide inhibitor of 5-LOX was designed by molecular modeling and kinetic assay was performed by spectrophotometry. The siRNA mediated 5-LOX gene silencing was performed to investigate the effect on proliferation of MDA-MB-231, breast cancer cell line. The serum 5-LOX level in breast cancer (5.69±1.97 ng/μl) was almost 2-fold elevated compared to control (3.53±1.0 ng/μl) (p D), 4.92 x 10-8 M. The siRNA mediated knockdown of 5-LOX, resulted in the decreased gene expression for 5-LOX and increased cell death in MDA-MB-231 cell line and thereby play a key role in reducing tumor proliferation. Thus, it can be concluded that 5-LOX is one of the potential serum protein marker for breast cancer and a promising therapeutic target for the same.Keywords
This publication has 28 references indexed in Scilit:
- Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator–Activated Receptor αThe Journal of Immunology, 2013
- The Relationship of Mammographic Density and Age: Implications for Breast Cancer ScreeningAmerican Journal of Roentgenology, 2012
- Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12: In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast CancerPLOS ONE, 2012
- Cyclooxygenases and lipoxygenases in cancerCancer and Metastasis Reviews, 2011
- Evaluation of human LOX-12 as a serum marker for breast cancerBiochemical and Biophysical Research Communications, 2011
- Prognostic Significance of Cyclooxygenase-2 and Response to Chemotherapy in Invasive Ductal Breast Carcinoma Patients by Real Time Surface Plasmon Resonance AnalysisDNA and Cell Biology, 2011
- The Structure of Human 5-LipoxygenaseScience, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Eicosanoids and cancerNature Reviews Cancer, 2010
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007